ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

ASCO Explores White, Minority Cancer Problem

July 13, 1990

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

House Authorizes $30M For Pediatric Cancer Research.

June 13, 2008

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004